| 1 |
35044568 | Postprandial Glucose Excursions in Asian Versus Non-Asian Patients with Type 2 Diabetes: A Post Hoc Analysis of Baseline Data from Phase 3 Randomised Controlled Trials of IDegAsp. | 2022 Feb |
4 |
| 2 |
35593434 | What is the value of faster acting prandial insulin? Focus on ultra rapid lispro. | 2022 May 19 |
1 |
| 3 |
35598134 | Indian Reality of Clinical Practice and Patient Profile in Diabetes Care: Lessons from the IMPACT survey. | 2022 May |
2 |
| 4 |
32277270 | Reducing postprandial glucose in dietary intervention studies and the magnitude of the effect on diabetes-related risk factors: a systematic review and meta-analysis. | 2021 Feb |
1 |
| 5 |
33730337 | A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes. | 2021 May |
1 |
| 6 |
33776458 | A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose. | 2021 |
1 |
| 7 |
33786271 | Basal insulin ameliorates post-breakfast hyperglycemia via suppression of post-breakfast proinsulin/C-peptide ratio and fasting serum free fatty acid levels in patients with type 2 diabetes. | 2021 Apr |
2 |
| 8 |
34150441 | Comparative effects of insulin glulisine and lispro on postprandial plasma glucose and lipid profile in Japanese patients with type 2 diabetes mellitus. | 2021 Jul |
1 |
| 9 |
30466191 | Mealtime fast-acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin-resistant Type 2 diabetes. | 2019 Jun |
4 |
| 10 |
31226281 | How often patients on insulin therapy measure postprandial glycemia and modify insulin doses accordingly? From an on-line survey in insulin-treated diabetes patients in Spain. | 2019 Aug |
1 |
| 11 |
29493118 | Greater early postprandial suppression of endogenous glucose production and higher initial glucose disappearance is achieved with fast-acting insulin aspart compared with insulin aspart. | 2018 Jul |
2 |
| 12 |
27986406 | Addition of once daily prandial lixisenatide to basal insulin therapy in patients with type-2 diabetes results in a reduction of HbA1c as an effect of postprandial glucose lowering. | 2017 Nov |
1 |
| 13 |
28117542 | The additional dose of insulin for high-protein mixed meal provides better glycemic control in children with type 1 diabetes on insulin pumps: randomized cross-over study. | 2017 Dec |
1 |
| 14 |
29032696 | Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes. | 2017 Nov |
1 |
| 15 |
25066229 | Glucagon-like peptide-1 receptor agonists as insulin add-on therapy in patients with inadequate glycemic control in type 2 diabetes mellitus: lixisenatide as a new therapeutic option. | 2015 Mar |
1 |
| 16 |
18667139 | Initiating insulin in patients with type 2 diabetes. | 2007 Aug |
1 |
| 17 |
16526817 | Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated? | 2006 |
1 |
| 18 |
16919548 | Targeting postprandial hyperglycemia. | 2006 Sep |
1 |